Four people sit around a table and talk. Franz Kranz’s lacerating play Mass is built from the simplest and least theatrical of ingredients. Yet in this production, thanks to the skill of director ...

This is an annual hands-on learning experience for students at Fairdale High School. Samuel Alito breaks with Clarence Thomas in Supreme Court decision We asked 3 dietitians to pick the healthiest ...

Adeel Akhtar and Lyndsey Marshal in Mass, photo by Richard Hubert Smith Photos have been released of the cast of Mass. Fran Kranz’s debut play is based on his 2021 film of the same name, following a ...

Two couples, both of whom have lost sons, meet in Fran Kranz’s unflinching look at restorative justice Fran Kranz’s 2021 film Mass, featuring two sets of parents whose sons have died in a high-school ...

Under-23 World Champion Lorenzo Finn is the biggest name to pull out, having started the day in sixth overall When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Teddi Mellencamp requested GLP-1 weight loss medication while battling Stage 4 cancer, but was promptly denied by her doctors. “I am a health and wellness coach who’s dying of cancer. And because I ...

FRANKFURT, April 28 (Reuters) - Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in a late-stage trial, as the ‌unlisted German drugmaker ...

Zealand Pharma (ZLDPF) announced on Tuesday that its GLP-1 candidate, survodutide, developed with German drugmaker Boehringer Ingelheim, met the primary goals in a late-stage trial, generating up to ...

Officials are looking for answers after a mass shooting at the Mall of Louisiana left one person dead and five others injured on Thursday. Baton Rouge Police Chief TJ Morse said that investigators ...

The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and orforglipron (Foundayo) seem like a magic bullet for weight loss. But using ...

Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the result fell short of the bar set by existing drugs, the German drugmaker is ...

The booster arrived by barge from Louisiana on Monday (April 27) after a journey of 900 miles (1,450 kilometers). When you purchase through links on our site, we may earn an affiliate commission. Here ...